Skip to main content
C

CoMind

CoMind develops a non‑invasive neuromonitoring system that uses a lightweight adhesive forehead sensor, wavelength‑modulated laser, and interferometric time‑of‑flight detection to continuously measure cerebral blood flow, intracranial pressure, autoregulation, and brain tissue oxygenation at the bedside. The high‑speed optical data are processed in real time and can be displayed on dedicated monitors or integrated with existing ICU and operating‑room equipment, giving clinicians continuous, actionable neurophysiological insights without invasive catheters.

London, United KingdomFounded 20188110K+ followers
Updated 2 months ago

Funding

$26.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current bedside monitoring of brain physiology is limited to invasive catheters or intermittent, indirect measurements, leaving clinicians without continuous, real‑time data on cerebral blood flow, autoregulation, intracranial pressure and tissue oxygenation. This gap hampers timely decision‑making in critical care, cardiac surgery and traumatic brain injury management.

Solution

CoMind is developing a non‑invasive neuromonitoring system that uses a lightweight, adhesive forehead sensor combined with a wavelength‑modulated laser and interferometric time‑of‑flight detection. The technology captures depth‑resolved optical signals at hundreds of thousands of samples per second, enabling continuous measurement of cerebral perfusion, autoregulation, intracranial pressure and brain tissue oxygen saturation. Data are processed in real time and can be displayed on a dedicated monitor or integrated into existing multiparameter bedside monitors, allowing clinicians to track neurophysiological trends without additional training or invasive procedures. By providing a broad suite of brain‑specific parameters from a single bedside measurement, the system aims to improve patient outcomes across the care continuum.

Target Audience

Primary customers are clinicians in intensive care units, cardiac and vascular surgery suites, and neurocritical care teams who require continuous, bedside brain monitoring for patients at risk of cerebral hypoperfusion or intracranial hypertension.

Features

  • Adhesive forehead sensor that requires minimal setup and no specialized operator expertise
  • Time‑of‑flight resolved interferometric optics delivering depth selectivity and absolute tissue optical property measurement
  • High‑speed detection (hundreds of kHz) capturing dynamic red‑blood‑cell flow fluctuations for accurate cerebral blood flow indexing
  • Multi‑parameter output including cerebral blood flow, intracranial pressure, autoregulation index, and brain tissue oxygen saturation
  • Compatibility with existing ICU and operating‑room monitors via standard display interfaces or API integration
  • Real‑time analytics pipeline that translates raw optical data into clinically actionable trends and alerts
This profile is AI-generated and may contain inaccuracies.